Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1153 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

VAYA Pharma introduces memory impairment drug

Vayacog, a once-daily formulation of phosphatidylserine – omega 3 compound, DHA enriched, is a prescription medical food. Regulated by the US Food and Drug Administration under the Orphan

Recombinant, MAVERIC to develop GenISIS

In working with the MAVERIC team, Recombinant uses its Agile Iterative Development approach to design and prototyping, and delivering production systems in a just-in-time mode to meet the

Mylan introduces generic Roxicodone

Mylan has launched the drug under its development and supply agreement with Coastal Pharmaceuticals. Oxycodone Hydrochloride (HCI) tablets USP, 5mg, 15mg and 30mg are the generic version of

Marken names new CEO

Wheeler will succeed Gerard Barba, who will continue his work as the chairman of the board of directors Before joining Marken, Wheeler served as the president and CEO